Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 5:25 PM
Ignite Modification Date:
2025-12-25 @ 2:59 PM
NCT ID:
NCT03695250
Group ID:
EG000
Title:
Treatment (BMS-986205 and Nivolumab)
Description:
Patients receive IDO1 inhibitor BMS-986205 PO QD on days 1-14 and nivolumab IV over 30 minutes on day 1. Courses repeat every 14 days in the absence of disease progression or unacceptable toxicity.
IDO1 Inhibitor BMS-986205: Given PO Nivolumab: Given IV
Deaths Number Affected:
4
Deaths Number At Risk:
None
Serious Number Affected:
2
Serious Number At Risk:
8
Other Number Affected:
8
Other Number At Risk:
8
Study:
NCT03695250
Results Section:
NCT03695250
Adverse Events Module:
NCT03695250